Prudo-Chlebosz Raymond
SEC insider (Form 3/4/5 filer). CIK 0001653262. Director at Akari Therapeutics Plc (AKTX). 10 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in TAMPA, FL.
Companies Prudo-Chlebosz Raymond has filed insider reports for
- Akari Therapeutics Plc (AKTX): Director
Prudo-Chlebosz Raymond
CIK: 0001653262
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akari Therapeutics Plc
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 5, 2026AKTX
Akari Therapeutics Plc
AwardDirect3.2K shares at avg. $7.90$26K - Aug 18, 2026AKTX
Akari Therapeutics Plc
AwardDirect9.1K shares at avg. $7.90$72K - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
618.7K shares at avg. $0.40- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase American Depositary Shares ("ADRs")
618.7K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectWarrants to purchase ADRs
386.7K shares- - Dec 16, 2025AKTX
Akari Therapeutics Plc
PurchaseDirectPre-Funded Warrants to purchase ADRs
386.7K shares at avg. $0.40- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
175K shares- - Mar 20, 2025AKTX
Akari Therapeutics Plc
AwardDirectStock Option (Right to Buy)
225K shares- - Mar 6, 2025AKTX
Akari Therapeutics Plc
AwardDirect446.4K shares at avg. $1.12$500K - Dec 2, 2024AKTX
Akari Therapeutics Plc
AwardDirect419.3M shares at avg. $0.00$503K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | AKTX Akari Therapeutics Plc | Award | 3,240 | $7.90 | $25,593 | Direct |
| Aug 18, 2026 | AKTX Akari Therapeutics Plc | Award | 9,072 | $7.90 | $71,660 | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 618,658 | $0.40 | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase American Depositary Shares ("ADRs") | 618,658 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Warrants to purchase ADRs | 386,661 | - | - | Direct |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | Purchase Pre-Funded Warrants to purchase ADRs | 386,661 | $0.40 | - | Direct |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 175,000 | - | - | Direct |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | Award Stock Option (Right to Buy) | 225,000 | - | - | Direct |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | Award | 446,428 | $1.12 | $499,999 | Direct |
| Dec 2, 2024 | AKTX Akari Therapeutics Plc | Award | 419,286,000 | $0.00 | $503,143 | Direct |
1-10 of 10 transactions